Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Beat The Street With SI Traders -- Ignore unavailable to you. Want to Upgrade?

To: Postman who wrote (91752)	12/19/2011 1:41:32 PM
From: E. Charters	Read Replies (1) \| Respond to of 233883

Most of these vaccines turn out to have limited effectiveness, and given the length of time it takes to develop the Cancer, it will be a long time before we know if it is worth it, and safe. I can't see a vaccine being not safe if it is against a Cancer and not a communicable disease, but you never know. EC<:-}

To: Postman who wrote (91752)	12/19/2011 1:49:10 PM
From: pocotrader	Respond to of 233883

I put GNBT on my Yahoo Bio tech watch list, I looked at their chart and noticed there is a 6 buck target price, with over 300 million OS that would give them a valuation of 1.89 billion, i think that that 6 buck target is wishful thinking, they haven't finished phase 2 yet, they still have a very long way to go, if however phase 2 was very successful there should be a nice pop, exposure on Bloomberg doesn't hurt either, breast cancer is on the minds of too many people, I'm sure everyone knows someone who has been stricken by that horrible disease.